Jeff Yass’s POMDOCTOR LIMITED Class A Ordinary Shares POM Stock Holding History

Jeff Yass’s Portfolio POM Stock Details POM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,282	Closed	-$15.2K	–	14954
2026 Q1	$15.2K	Buy	+3,282	New	+$16.8K	﹤0.01%	12896

Other funds holding POM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Jeff Yass's POM Position: Q2 2026 in Review

Jeff Yass sold out of POMDOCTOR LIMITED Class A Ordinary Shares (POM) in Q2 2026, closing a stake of 3,282 shares — an estimated $15.2K sold.

Jeff Yass first reported a position in POM in Q1 2026 and held it in 1 quarter. The position peaked at $15.2K in Q1 2026. 6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

Jeff Yass reported no remaining POMDOCTOR LIMITED Class A Ordinary Shares position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 3,282 POMDOCTOR LIMITED Class A Ordinary Shares shares in Q2 2026, an estimated $15.2K.
Jeff Yass first reported a position in POMDOCTOR LIMITED Class A Ordinary Shares in Q1 2026 and held it in 1 quarter.
Jeff Yass's POMDOCTOR LIMITED Class A Ordinary Shares position peaked at $15.2K in Q1 2026.
6 funds tracked by Wall St. Rank held POMDOCTOR LIMITED Class A Ordinary Shares as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.